tiprankstipranks
Advertisement
Advertisement

MDCX Stock Latest News

Medicus Pharma announces results from Phase 2 SKNJCT-003 analysis
The FlyMedicus Pharma announces results from Phase 2 SKNJCT-003 analysis
16h ago
MDCX
Medicus Pharma meets with lawmakers to support SkinJect designations
PremiumThe Fly
Medicus Pharma meets with lawmakers to support SkinJect designations
10d ago
MDCX
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines
PremiumRatings
Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines
12d ago
MDCX
Medicus Pharma Expands ATM Equity Program for Funding
PremiumCompany Announcements
Medicus Pharma Expands ATM Equity Program for Funding
13d ago
8K
MDCX
Medicus Pharma initiated with a Buy at Roth Capital
PremiumThe Fly
Medicus Pharma initiated with a Buy at Roth Capital
16d ago
MDCX
Medicus Pharma submits ODD application to U.S. FDA for SkinJect
PremiumThe FlyMedicus Pharma submits ODD application to U.S. FDA for SkinJect
20d ago
MDCX
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
Premium
Company Announcements
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy
22d ago
MDCX
Medicus Pharma enters media partnership with New to The Street
Premium
The Fly
Medicus Pharma enters media partnership with New to The Street
1M ago
MDCX
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
PremiumCompany Announcements
Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market
1M ago
MDCX
Medicus Pharma submits clinical study design to FDA for Teverelix
PremiumThe Fly
Medicus Pharma submits clinical study design to FDA for Teverelix
1M ago
MDCX
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
PremiumCompany Announcements
Medicus Pharma Sharpens SkinJect Phase 2 Narrative, Pivots to 200µg Dose for Registrational Path
1M ago
MDCX
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
PremiumCompany Announcements
Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate
1M ago
MDCX
Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
PremiumCompany AnnouncementsMedicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2
1M ago
MDCX
Medicus Pharma reports principal investigator validation of Phase 2 data
Premium
The Fly
Medicus Pharma reports principal investigator validation of Phase 2 data
1M ago
MDCX
Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan
Premium
Company Announcements
Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan
1M ago
MDCX
Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy
PremiumCompany Announcements
Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy
1M ago
MDCX
Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat
PremiumCompany Announcements
Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat
2M ago
MDCX
Medicus Pharma to discuss Skinject Phase 2 reults in fireside chat
PremiumThe Fly
Medicus Pharma to discuss Skinject Phase 2 reults in fireside chat
2M ago
MDCX
Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call
PremiumCompany Announcements
Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call
2M ago
MDCX
Medicus Pharma announces SkinJect Phase 2 KOL update
PremiumThe FlyMedicus Pharma announces SkinJect Phase 2 KOL update
2M ago
MDCX
Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum
Premium
Company Announcements
Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum
2M ago
MDCX
Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma
Premium
Company Announcements
Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma
2M ago
MDCX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >